Physician profile
Anthony B Davis
NPI 1285722991
$4,270.74
in general payments reported to CMS, 2019-2025
27 companies · $606 in 2025
The $606 reported for 2025 was more than what 75% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $770 · 2022: $768 · 2023: $1,346 · 2024: $780 · 2025: $606.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,724 · Education: $8.16.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,724.36 |
| Education | $8.16 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Axonics, INC. | $875.38 | 2021-2024 | Axonics, Bulkamid |
| Coloplast Corp | $483.97 | 2021-2025 | Titan, Speedicath |
| Endo Pharmaceuticals INC. | $388.16 | 2021-2024 | Xiaflex, Aveed |
| Astellas Pharma US INC | $376.53 | 2021-2023 | Veozah, Myrbetriq |
| Sumitomo Pharma America, INC. | $368.86 | 2023-2025 | Orgovyx, Gemtesa |
| Boston Scientific Corporation | $256.44 | 2021-2025 | Ams 700, Lumenis Pulse 120h, Spaceoar Vue System - 10ml |
| Tolmar, INC. | $170.20 | 2023-2025 | Eligard, Jatenzo |
| Urogen Pharma, INC. | $167.04 | 2025 | |
| Laborie Medical Technologies Corp. | $166.92 | 2024-2025 | Optilume Bph Drug Coated Balloon Catheter |
| Myovant Sciences INC. | $143.36 | 2021-2022 | |
| Procept Biorobotics Corporation | $143.16 | 2024 | Aquabeam System |
| Olympus America INC. | $137.50 | 2023 | Itind System |
| Urovant Sciences INC | $107.28 | 2021-2022 | |
| Teleflex LLC | $91.24 | 2023-2024 | Urolift |
| Endo USA, INC. | $54.43 | 2024-2025 | Xiaflex |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Vertex Pharmaceuticals Incorporated | $53.28 | 2025 | |
| Abbvie INC. | $48.99 | 2021-2023 | |
| Progenics Pharmaceuticals, INC. | $45.33 | 2022 | |
| Mimedx Group, INC. | $32.56 | 2024-2025 | |
| Palette Life Sciences, INC. | $30.85 | 2022 | |
| Dendreon Pharmaceuticals LLC | $25.74 | 2025 | Provenge |
| Daiichi Sankyo INC. | $23.76 | 2022 | |
| Medtronic, INC. | $21.17 | 2024 | Interstim |
| Conmed Corporation | $17.50 | 2024 | Airseal |
| Pacira Pharmaceuticals Incorporated | $16.15 | 2025 | Exparel |
| Integra Lifesciences Corporation | $13.57 | 2021 | |
| Janssen Biotech, INC. | $11.37 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Anthony Davis listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.